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Two major metabolites and one minor metabolite of sulfadiazine were found in pig manure,
using a special combination of different MS techniques like parent and product ion scans, H/D
exchange, accurate mass measurement, and MS/MS experiments with substructures. N4-
acetylsulfadiazine and 4-hydroxysulfadiazine were identified as major metabolites. N4-
acetylsulfadiazine could be verified by H/D exchange and comparison with product ion
spectra of a synthetic reference compound. In the case of 4-hydroxysulfadiazine, the majority
of possible isomers could be discounted after H/D exchange. Substructure-specific MS/MS
experiments with fragment ions and comparison with product ion spectra of two references
revealed the presence of 4-hydroxysulfadiazine. The minor metabolite was characterized to
some degree using H/D exchange and tandem mass spectrometry in combination with a
high-resolution time of flight mass spectrometer. The aminopyrimidine moiety contained an
additional modification with a likely elemental composition of C2H4O and no further acidic
hydrogen. (J Am Soc Mass Spectrom 2005, 16, 1687–1694) © 2005 American Society for Mass
SpectrometryIn agriculture, several classes of pharmaceuticals areused [1–2]. Antibiotics and antimicrobial agents areused for both therapeutic and prophylactic purposes
in addition to their application as growth promoters.
The antimicrobial sulfonamides are one class of phar-
maceuticals that is widely used. As a consequence,
these compounds have been found in surface and
ground water, liquid manure, and soil [3–12]. After
administration to animals, the majority of the pharma-
ceuticals used are excreted unchanged or as phase I and
phase II metabolites. As part of an environmental risk
assessment, these metabolites also have to be character-
ized because phase I metabolites can still be active
against bacteria and phase II metabolites can be con-
verted back to the parent drug or phase I metabolites.
Moreover, very little is known about the capacity of
microbiological decay and the occurrence of new me-
tabolites after incubation for several months in a ma-
nure tank.
There are only a few references describing the me-
tabolism of sulfadiazine in pigs [13, 14]. After intrave-
Published online August 11, 2005
Address reprint requests to Dr. T. Pfeifer, Metabolite Service, Wicherntrasse
5, D-01445 Radebeul, Germany. E-mail: thomas.pfeifer@elbion.de
© 2005 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/05/$30.00
doi:10.1016/j.jasms.2005.06.008nous administration of 40 to 60 mg sulfadiazine per kg
body weight to male pigs without coadministration of
trimethoprim, only low levels of metabolites have been
observed. The N-acetyl sulfadiazine was the main me-
tabolite in plasma. Traces of 4-hydroxysulfadiazine
were also detected. N-acetyl sulfadiazine and 4-hy-
droxysulfadiazine were the major metabolites in urine
collected up to three hours after application. No further
metabolites were identified and investigations in feces
were not carried out.
The aim of the present work was to use different
mass spectrometric strategies to identify possible me-
tabolites of the widely used drug sulfadiazine in ma-
nure originating from a pig farm. The metabolites of
interest should still have a similar structure as the
parent drug and, therefore, retain to a greater or lesser
extent their bioactive profile against micro-organisms.
Earlier investigations about the biological activity of
metabolites showed action of hydroxylated metabolites
of sulfadiazine against different bacterial strains in
contrast to N-acetyl sulfadiazine, which showed no
antimicrobial activity [15–17]. In the latter case, how-
ever, biological activity could be regained after a
possible cleavage of the N-acetyl group by micro-
organisms yielding the parent drug.
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Materials
Water and acetonitrile (HPLC grade) were obtained
from Baker (Deventer, The Netherlands). All other
solvents (Suprasolv grade) were obtained from Merck
(Darmstadt, Germany). Ammonium acetate, sodium
hydroxide pellets, glacial acetic acid, formic acid, 25%
aqueous ammonia, toluene, boron tribromide, citric
acid monohydrate, sodium dihydrogen phosphate di-
hydrate, sodium chloride, sodium hydrogen carbonate,
and anhydrous sodium sulfate were of analytical grade
and purchased from Merck. Sulfadiazine was pur-
chased from Fluka (Seelze, Germany). All other sub-
stances and references were obtained from Sigma (Dei-
senhofen, Germany). The manure sample originated
from a farm which had administered sulfadiazine to
pigs two months before sampling. A total amount of 2
kg sulfadiazine was administered to pigs and the tank
had a volume of 1000 m3.
Synthesis of Metabolite N4-Acetyl Sulfadiazine
Sulfadiazine (400 mg) was dissolved in 25 mL pyridine,
and 2 mL of acetic anhydride was added. The mixture
was heated for two h at 80 °C in a water bath. After
cooling, 5 mL of aqueous ammonia solution (25% NH3)
and 5 mL of water were added and the mixture was
allowed to react at 25 °C for 30 min (hydrolysis of a side
product). The resulting solution was acidified to pH 2
with concentrated hydrochloric acid (25%). The product
was extracted twice with 200 mL ethyl acetate. The
organic phases were collected, washed with an aqueous
solution (0.1% acetic acid), and dried over sodium
sulfate. The dried ethyl acetate phase was evaporated
using a rotary evaporator and the solid residue was
taken up in 50 mL methanol. Methanol was evaporated
(to remove any residual acetic acid) and the procedure
was repeated twice. The residue was dried over phos-
phorus pentoxide. Purity was checked by HPLC (99%),
HPLC-MS, and elemental analysis (C12H12N4O3S, calcu-
lated/found: C 49.3%/48.8%, H 4.1%/4.3%, N 19.2%/
19.0%). The yield of N4-acetyl sulfadiazine was 45%.
Synthesis of Reference 5-Hydroxysulfadiazine
To a stirred solution of 1.07 g 5-methoxysulfadiazine in
20 ml dry toluene, 0.27 mL boron tribromide was added
dropwise. The mixture was heated at 80 °C for two h,
then allowed to stand at room-temperature and the
precipitated product to filter off. The product was
washed with toluene and dried carefully in vacuum.
The dried residue was hydrolyzed with 0.6 M aqueous
solution of sodium hydrogen carbonate for 30 min. The
mixture was filtered and the residue dried. The yield of
5-hydroxysulfadiazine was 40%. According to NMR
data, the product consisted of 50% 5-methoxysulfadia-
zine and 50% 5-hydroxysulfadiazine.Sample Preparation
Extraction. After administration of sulfadiazine to
pigs, the manure was stored in a tank at 0 °C for two
months. The manure sample was homogenized for 10
min at 25,000 rpm using an ultra Turrax homogenizer
(VF2/IKA, Staufen, Germany). A sample of homoge-
nized manure (15 g) was weighed into a 75 mL centri-
fuge glass with a screw cap (Schott, Mainz, Germany)
and 4 g of sodium chloride was added. The sample was
buffered to pH 5.5 by addition of 3 mL modified
McIlvaine buffer (1 M citric acid, 1 M Na2HPO4, ad-
justed to pH 5.5 with NaOH pellets).
Liquid-liquid extraction. The buffered manure sample
was treated with 15 mL of a solvent mixture containing
95% n-hexane and 5% ethyl acetate (vol/vol) for lipid
removal. The mixture was shaken for 15 min by means
of a horizontal shaker from Koettermann (type 4020,
Haenigsen, Germany) at 150 min1. The phases were
separated by centrifugation at 3400 g for 15 min. The
organic phase was removed and discarded. Sulfadia-
zine and metabolites were extracted twice from the
aqueous phase by liquid-liquid extraction with 45 mL of
ethyl acetate, with shaking (15 min) and centrifugation
(3400 g for 15 min). The resulting ethyl acetate extracts
were pooled, dried with anhydrous sodium sulfate
overnight, and filtered through a paper filter. The
solvent was evaporated using a rotary evaporator. The
residue was reconstituted in 1 ml 50 mM ammonium
acetate containing 30% methanol and filtered through a
syringe filter (0.45 m, YMC Europe, Schermbeck, Ger-
many). The pH of the aqueous phase of this buffer was
adjusted to pH 3.5 by addition of acetic acid.
HPLC. Separations were performed using a Luna
RP18 column (2 mm i.d., length 100 mm, particle size 3
m) with a SafetyGuard (Phenomenex, Torrance, CA)
at 30 °C. The flow rate was 0.3 mL/min. The HPLC
gradient was produced by using two mobile phases.
Phase A consisted of 5% acetonitrile in water (vol/vol)
with 0.1% HCOOH (vol/vol) and 1 mM ammonium
acetate. Phase B consisted of 0.1% HCOOH (vol/vol) in
pure acetonitrile. Chromatographic separation was
achieved with the following gradient: 0 min 5% B, 5.5
min 40% B, 6 min 100% B, 8.5 min 100% B, 9 min 5% B,
16 min 5% B. Injections of 10 L were made from each
sample. The HPLC system consisted of a Perkin Elmer
autosampler AS200, an Agilent HP 1100 HPLC pump, a
degasser unit and a column oven (all from Agilent,
Waldbronn, Germany). After HPLC separation, the
individual compounds were analyzed by LC-MS/MS in
positive ion mode. During H/D exchange experiments
the water was replaced by D2O. The solvent bottle was
replaced by a smaller one with a volume of 100 mL.
Thus, a total amount of 100 mL D2O was sufficient to
carry out many H/D exchange HPLC runs for a full
day.
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trometer (API 3000, Applied Biosystems, Darmstadt,
Germany) was equipped with a Turbo Ionspray source
and operated under the following conditions: tempera-
ture, 450 °C; gas1 (nebulizer), 10; gas2 (heater), 5000
L/min; curtain gas, 10; IS voltage, 5 kV; vaporizer
temperature, 450 °C; DP, 60 V; FP, 240 V; DXP, 15 V; CE,
30 eV; collision cell pressure, 4; collision gas nitrogen;
multiplier, 2700 V; peak width at half height, 0.7 Da. For
in-source fragmentation experiments, the DP and FP
were adjusted to 80 and 280 V, respectively. The scan
range for precursor ion scans was m/z 100 to 600 and
collision energies of 30 and 50 eV were utilized. The
data obtained were processed by the Analyst 1.2 soft-
ware. A postcolumn Valco divert valve was used to
direct most of the nonsignificant LC-flow of a sample to
waste. Diverting the flow minimized contamination of
the MS source: 0–2 min divert to waste, 2–8 min flow to
mass spectrometer, 8–16 min divert to waste. An addi-
tional flow of 100 L/min water/acetonitrile (50/50%,
vol/vol) with 0.1% HCOOH compensated the missing
flow from the HPLC during waste position operation.
Automatic data acquisition was triggered using a con-
tact closure signal from the autosampler.
Figure 1. Precursor ion chromatogram of fragment ion m/z 108,
typical of the sulfonamide moiety, at 30 eV collision energy. The
following compounds were identified: Compound 1 singly oxi-
dized metabolite (16 mass units); Compound 2 sulfadiazine;
Compound 3 N4-acetylsulfadiazine (42 mass units), Compound
4 unknown metabolite with m/z 295 (44 mass units).
Table 1. Signals observed during different precursor ion scans i
and 156) or unmodified aminopyrimidine moiety (m/z 96)
Compound RT min M 
1) N-Oxide or Hydroxysulfadiazine 3.34 2
2) Sulfadiazine 4.06 2
3) Acetylsulfadiazine 4.43 2
4) Unknown 5.02 2
 Weak signal due to low concentration.
 Good signal.
 No signal.
/ Very weak signal.Exact mass measurements were performed using a
Micromass Q-TOF Ultima API mass spectrometer (Wa-
ters, Manchester, United Kingdom) equipped with a
dual ESI source (LockSpray) operated in the positive
ion mode at a resolution of 10,000 FWHM. The ammo-
nium acetate in HPLC phase A was removed during
accurate mass measurements because of a contamina-
tion interfering with the analysis of Compound 4. The
cone voltage was set at 35 V, the capillary voltage was
3 kV, the desolvation temperature was 350 °C, and the
source temperature was 120 °C. Collision energy of 30
eV was used for all MS/MS experiments. A cluster ion
of phosphoric acid was used as internal reference
infused via the second probe of the LockSpray source.
Data were acquired in the continuummode from m/z 50
to 1000 with a scan time of 0.5 s, and processed using
Masslynx 4.0 software. A typical uncertainty of exact
mass measurement below m/z 150 is 1.5 mDa under
standard conditions.
Results and Discussion
Parent ion scans, neutral loss scans, and information-
dependant acquisition scans [18 –23] are useful mass
spectrometric tools to find metabolites in more or less
complex matrices. During this study, we used different
parent ion scans for the ethyl acetate extract and parent
ion and neutral loss scans for the remaining aqueous
phase after liquid/liquid extraction of manure. The
discussion is focused on the results obtained from the
ethyl acetate phase, since no additional metabolites
(e.g., glucuronidation, sulfation) were found in the
remaining aqueous phase of manure.
Characteristic fragmentation pathways of sulfon-
amides were summarized, for instance in reference [24].
After collisional activation of the [M  H] ion of
sulfadiazine, intense signals were observed at m/z 92,
108, and 156 (typical sulfonamide fragments) contain-
ing the sulfonamide moiety and atm/z 96 containing the
aminopyrimidine ring. These fragment ions were used
to identify potential metabolites with intact sulfon-
amide or aminopyrimidine moiety via precursor ion
scans with the above mentioned key fragment ions. An
example is shown for the precursor ion scan with
fragment ion m/z 108 (Figure 1).
ting an unmodified sulfonamide (fragment ions m/z 92, 108,
/z
Signal for precursor ion scan of
m/z 92 m/z 108 m/z 156 m/z 96
   
   
   






1690 PFEIFER ET AL. J Am Soc Mass Spectrom 2005, 16, 1687–1694The results of all precursor ion scans are summarized
in Table 1. Besides sulfadiazine, two major metabolites
and one minor metabolite could be identified in the
extract (Compounds 1, 3, and 4).
Potential precursor ions were identified (m/z 267,
251, 293, and 295 for the [M  H] ion), and further
investigated by MS/MS. Key fragment ions of sulfadi-
azine and metabolites are summarized in Scheme 1. The
letter Y indicates a possible modification of the pyrim-
idine moiety. Metabolites modified in the aminopyrimi-
dine moiety showed the expected shift of the key
fragment ion at m/z 158 and m/z 96 by the respective
mass (Y) leading to corresponding fragment ions. An
ellipse illustrates the modified part of the molecule. The
product ion spectra of all identified compounds and
Figure 2. Product ion spectra of [MH] ions
metabolite, (c) singly oxidised metabolite, (d) u
units, and (e) reference 5-hydroxysufadiazine. A
Scheme 1the purified extract.references are shown in Figure 2. The MS/MS spectrum
of the more polar metabolite (Table 1, Compound 1)
showed a shift of the fragment ion with m/z 96 of
sulfadiazine to m/z 112, but no shift of the fragment ions
containing solely the sulfonamide moiety (m/z 92, 108
and 156). The data are only in agreement with an
oxidation of the aminopyrimidine group. Compound 2
could be identified as intact sulfadiazine by comparison
with a reference (identical RT and MS/MS spectrum).
Compound 3 showed a mass shift of 42 of all frag-
ment ions containing the sulfonamide moiety (m/z 134,
150, and 198), which is consistent with N4-acetyl sulfa-
diazine. It is interesting to note that the rearranged
fragment ion at m/z 108 is also formed despite the
acetylated amino group. This fragment ion is probably
formed by elimination of H2C¢C¢O from the fragment
ion with m/z 150. A synthesized reference of N4-acetyl
sulfadiazine produced identical product ion spectra
and no difference in retention time during co-
chromatography (not shown). The most hydrophobic
metabolite (Compound 4, low abundance) showed a
shift of the fragment ion at m/z 96 (sulfadiazine) to
m/z 140 and again no shift of fragment ions typical of
the sulfonamide moiety, indicating a modification of
the aminopyrimidine moiety. The fragment ion m/z
140 is in accordance with the complementary sulfon-
amide fragment m/z 156, similar to sulfadiazine (m/z
96) and Compound 1 (m/z 112, Scheme 1). Compared
with Compound 1, the reference 5-hydroxysulfadia-
sitive ion mode of (a) sulfadiazine, (b) acetylated
wn metabolite with a mass shift of 44 mass
ctra except for reference (e) were obtained fromin po
nkno
ll spe
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(Figure 2c and e). However, the fragment ion at m/z
201 resulting from a rearrangement (M  H 
H2SO2) was only observed for the reference com-
pound and both compounds showed different reten-
tion behavior on RP 18 HPLC (RT reference 3.9 min,
RT metabolite 3.34 min). Unfortunately, many questions
remained about the position of oxidation of this most
polar metabolite and the nature of the less abundant
metabolite (Compound 4).
H/D Exchange
Knowing the number of acidic hydrogens indicated by
H/D exchange experiments is a great advantage during
structure elucidation. Surprisingly, this method has
infrequently been applied for characterization of metab-
olites [25–33]. The higher cost of D2O could be consid-
ered a certain drawback, but the consumption of D2O
can be significantly reduced by using smaller columns
and smaller solvent bottles. Alternatively, fractions can
be collected and redissolved in D2O containing sol-
vents.
H/D exchange needs no reference compounds and is
useful in differentiation of S or N oxides resulting in no
mass shift, and hydroxylation of C atoms leading to a
shift of one mass unit after incorporation of one deute-
rium atom at the newly formed hydroxy group. More-
over, the presence of adducts with sodium or ammo-
nium could be observed, which is sometimes useful in
the verification of the unfragmented molecular ion.
H/D exchange experiments were performed during
this study to reduce the number of possible structural
Table 2. Acidic protons observed for sulfadiazine and
respective metabolites after changing of Mobile Phase A
from water to D2O







295 4 3Scheme 2isomers for Compound 1. These experiments were also
very helpful to confirm the metabolite N4-acetylsulfa-
diazine and to get more insight into the structure of the
minor Compound 4.
When D2O is used as mobile phase instead of water,
a [M  D] ion is formed in positive ion mode with
additional exchange of all acidic hydrogens in the
molecule by deuterium. The observed mass shifts of all
compounds after chromatography of the extracts with
D2O were summarized in Table 2. Sulfadiazine showed
an expected incorporation of three deuterium atoms
(two at the amino group, one at the SO2NH- moiety).
Compound 4 showed also an incorporation of three
deuterium atoms. Together with the information from
the MS/MS spectrum, revealing an intact sulfonamide
group, it was proven that there was no further incor-
poration of an acidic hydrogen (no hydroxylation)
compared with sulfadiazine. The product ion spectrum
of deuterated Compound 4 (not shown) resulted in a
shift of fragment ion m/z 140 to 143, in accordance with
three deuterium atoms at the amino moiety similar to
the fragment ion m/z 96 of sulfadiazine (shift to m/z 99,
Scheme 1). Acetylsulfadiazine incorporated only two
deuterium atoms, one at the acetylated amino group
and one at the SO2NH- group as expected.
Figure 3. Comparison between product ion spectra of (a) refer-
ence 5-hydroxy-2-aminopyrimidine, (b) reference compound
4-hydroxy-2-aminopyrimidine, and (c) the in source formed frag-
ment ion with m/z 112 of the hydroxy metabolite.Scheme 3
1692 PFEIFER ET AL. J Am Soc Mass Spectrom 2005, 16, 1687–1694Compound 1 showed a mass shift of 16 mass units
compared with sulfadiazine and was consistent with an
oxidation product. On the basis of MS/MS spectra,
several hydroxylation, N-oxide (Scheme 2) or less likely
epoxide products were possible. To distinguish be-
tween these many isomers, H/D-exchange experiments
were also performed. The metabolite showed an incor-
poration of four deuterium atoms, two at the amino
group, one at the SO2NH- group, and an additional
one in accordance with a hydroxy function. Thus, the
obtained data were only consistent with the two hy-
droxy pyrimidine isomers in Scheme 2. The other two
N-oxidized isomers could be excluded, because in these
cases, incorporation of one deuterium less would be
expected. An alternative N-oxide could also be proven
by APCI-MS, producing a distinct [M  H  O] ion
due to decomposition in the ion source [34 –36]. In the
case of 4- or 5-hydroxysulfadiazine, however, this ion
would not be observed.
Substructure-Specific Fragmentation
After H/D exchange experiments, two hydroxy isomers
remained as possible structures for Compound 1
(Scheme 2a and b). To distinguish between the two
isomers a substructure specific MS/MS approach was
applied. To this end, the two possible substructures 4-
and 5-hydroxy-2-aminopyrimidine which could be pur-
chased were analyzed by LC-MS/MS. The resulting
fragment ion spectra (Figure 3) were compared with the
spectrum produced by in-source fragmentation. The
proposed fragmentation of the two reference com-
pounds 5-hydroxy-2-aminopyrimidine and 4-hydroxy-
2-aminopyrimidine is illustrated in Scheme 3. From the
Figure 4. Time-of-flight product ion spectrum of Compound 4 at
30 eV collision energy.
Table 3. Determined exact masses for intense fragment ions of
the minor Compound 4. The mass of the electron missing for









C6H6NO2Sa 1.4 156.0117 156.0119
C6H10N3O 11.5 140.0840 140.0824
C6H6NOa 8.0 108.0458 108.0449
C6H6Na 1.9 92.0502 92.0500
aFragment ions with an asterisk are typical sulfonamide fragments. An
intense fragment ion with m/z 92 was only observed at 30 eV with the
TOF-MS instrument but not with the triple quadrupole.subsequent MS/MS analysis of the fragment ion m/z
112 (containing one of the two possible hydroxyami-
nopyrimidins), only one reference and the primary
fragment ion of the metabolite produced an identical
MS/MS spectrum. According to the MS/MS spectra,
the fragment ion substructure of the hydroxy metabo-
lite was only in agreement with 4-hydroxy-2-aminopy-
rimidine. This technique was particularly useful be-
cause only a small part of the metabolite structure was
necessary as reference. Moreover, the smaller molecule
produced a more specific fragmentation pattern with
respect to the modified part of the molecule. This
property was attributable to the more effective transfer
of energy to the molecule with a lower number of
degrees of freedom. Thus, fragment ions were observed
for substructures that could not be obtained from the
intact metabolite (Figure 2), even in the case of higher
collision energy.
The nature of the minor metabolite could not be
determined unequivocally. An exact mass of the intact
molecule could be determined with a high-resolution
time of flight mass spectrometer. The obtained value for
M  H (295.0877) is in agreement with the proposed
elemental composition C12H15N4O3S (theoretical mass
 295.0865, error 4.1 ppm, see below). By applying
MS/MS (Figure 4), an accurate mass could also be
obtained for the fragment ion at m/z 140, containing the
modification (m/z 9644). Within the obtained mass
accuracy (about 1.5 mDa below m/z 150) a likely ele-
mental composition for Y could be determined. Table 3
displays the determined mass accuracy and most likely
elemental compositions for intense key fragment ions of
the minor metabolite. At 30 eV collision energy, an
intense fragment ion with m/z 92 was only observed
with the TOF-MS (Figure 4) but not with the triple
quadrupole (Figure 2d) which is probably attributable
to a higher activation of the M  H ion in the QTOF
collision cell and the better sensitivity of TOF MS.
Because of these different experimental conditions, the
fragment ion m/z 140 was one of the most abundant
fragments in the QTOF product ion spectrum of Com-
Scheme 4
Table 4. Possible elemental compositions for fragment ion m/z









C4H8N6 21.4 140.0810 4
C6H10N3O 11.4 140.0824 3.5
C8H12O2 2.1 140.0837 3
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It must be emphasized that the obtained spectrum of
Compound 4 had a very low signal to noise ratio.
Therefore, the mass tolerance was slightly increased
compared with the standard performance of the mass
spectrometer (see Experimental). The following general
parameters were utilized: odd and even electron ions;
RDBE, 0.5 to 30; number of carbon atoms, 0 to 25;
number of hydrogen atoms, 0 to 50; number of nitrogen
atoms, 0 to 10; number of oxygen atoms, 0 to 10; number
of sulphur atoms, 0 to 2; tolerance 3.5 mDa (25 ppm,
ACD 7.0 ver. 7.08, Toronto, Canada). The most likely
elemental composition was C6H10N3O with an odd
number of electrons leading to a residual composition
of OC2H4 for Y (Scheme 4). Table 4 summarizes other
less likely elemental compositions. Together with the
H/D experiments it was clear that the modification
contained no hydroxy group (Table 2). A possible
structure of this minor metabolite is shown in Scheme 4.
Several different combinations are possible; e.g., forma-
tion of an ethoxy moiety or a combination of methyl-
ation and formation of a methoxy moiety. However,
this is only an assumption. Quite unusual metabolites
might be formed because an incubation of the drug and
metabolites took place for two months under reductive
microbial conditions.
Conclusions
Two major metabolites and one minor metabolite of
sulfadiazine were found in pig manure using a combi-
nation of different MS techniques. The minor metabolite
was characterized to some degree using H/D exchange
and LC-MS/MS in combination with a high-resolution
time of flight mass spectrometer. The aminopyrimidine
moiety contained an additional modification with a
likely elemental composition of C2H4O and no fur-
ther acidic hydrogen. N4-acetylsulfadiazine and 4-
hydroxysulfadiazine were identified as major metabo-
lites in manure; 5-hydroxysulfadiazine has also been
described in different animals [16, 37, 38] but could be
excluded using a substructure specific MS/MS ap-
proach with primary fragment ions containing the
modified part of the compound. Moreover, further
possible oxidation products could be discounted using
H/D exchange experiments, reducing the number of
necessary reference compounds. In this case, the com-
bination of H/D exchange and substructure specific
MS/MS experiments was especially useful. The envi-
ronmental relevance of the results was underlined by
the fact that N4-acetylsulfadiazine, a phase II metabo-
lite, was already found in pig manure in higher concen-
trations than the administered parent drug [7].
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